126807-08-7 Usage
Uses
Used in Pharmaceutical Research:
3-Bromo-4-nitroindole is used as a research compound for its potential bioactivity, serving as a key intermediate in the synthesis of various pharmaceutical agents. Its reactivity and structural characteristics make it a valuable component in the development of new drugs.
Used in Chemical Synthesis:
In the field of organic chemistry, 3-bromo-4-nitroindole is used as a synthetic building block, contributing to the creation of more complex molecules. Its bromoand nitrosubstituents provide opportunities for further chemical reactions, allowing for the construction of a wide range of organic compounds.
Used in Research and Development Laboratories:
3-Bromo-4-nitroindole is employed as a reagent in research settings, where its properties are studied and utilized in various chemical processes. Understanding its stability, reactivity, and safety measures is essential for its effective and safe use in laboratory applications.
Check Digit Verification of cas no
The CAS Registry Mumber 126807-08-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,8,0 and 7 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 126807-08:
(8*1)+(7*2)+(6*6)+(5*8)+(4*0)+(3*7)+(2*0)+(1*8)=127
127 % 10 = 7
So 126807-08-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H5BrN2O2/c9-5-4-10-6-2-1-3-7(8(5)6)11(12)13/h1-4,10H
126807-08-7Relevant academic research and scientific papers
TOTAL SYNTHESIS OF THAXTOMIN A ANALOGUES AND THEIR INTERMEDIATES
-
Paragraph 0049; 0050, (2014/09/30)
Improved synthetic methods for the production of thaxtomin analogues, particularly thaxtomin A, and intermediates therefore such as substituted tryptophans and in particular, 4-nitro-L-tryptophan, and substituted phenyl acrylic acids are disclosed. Bioass
FUSED PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY ON FMS KINASES
-
Page/Page column 38, (2014/01/17)
Disclosed are a fused pyrimidine derivative of formula (I), and a pharmaceutically acceptable salt, stereoisomer, hydrate and solvate thereof, which have an excellent inhibitory activity on FMS kinases, and a pharmaceutical composition comprising the same is effective in preventing or treating diseases caused by abnormal activation of FMS kinases such as immunologic diseases, metabolic diseases, inflammatory diseases, cancers and tumors.
